Fig. 1: Immunostaining of MAP1LC3B in PCa and normal prostate tissues.

A Low expression of MAP1LC3B detected in normal prostate tissues. B–D High expression of MAP1LC3B detected in prostate cancer tissues. E, F Statistical analysis revealed MAP1LC3B was lowly expressed in non-cancerous prostate tissues, whereas highly expressed in PCa tissues, and correlated positively with Gleason score.